Insights

Loading spinner
Gathering insights about Novartis Vaccines

Novartis Vaccines Tech Stack

Novartis Vaccines uses 8 technology products and services including Enablon, SciPy, Prometheus, and more. Explore Novartis Vaccines's tech stack below.

  • Enablon
    Accounting And Finance
  • SciPy
    Advanced Analytics And Data Science
  • Prometheus
    Data Management
  • SAP BW/4HANA
    Data Warehousing
  • NoSQL
    Database
  • Selenium
    Frameworks And Libraries
  • APS
    Human Resource Management System
  • ValGenesis iRisk
    Risk And Compliance

Media & News

Novartis Vaccines's Email Address Formats

Novartis Vaccines uses at least 1 format(s):
Novartis Vaccines Email FormatsExamplePercentage
First.Last@novartis.comJohn.Doe@novartis.com
89%
F.Last@novartis.comJ.Doe@novartis.com
5%
FiLast@novartis.comJoDoe@novartis.com
3%
FLast@novartis.comJDoe@novartis.com
3%

Frequently Asked Questions

What is Novartis Vaccines's phone number?

Minus sign iconPlus sign icon
You can contact Novartis Vaccines's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Novartis Vaccines's official website and social media links?

Minus sign iconPlus sign icon
Novartis Vaccines's official website is novartis.com and has social profiles on LinkedIn.

What is Novartis Vaccines's NAICS code?

Minus sign iconPlus sign icon
Novartis Vaccines's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Novartis Vaccines have currently?

Minus sign iconPlus sign icon
As of December 2025, Novartis Vaccines has approximately 5K employees across 6 continents, including North AmericaEuropeAsia. Key team members include CEO: C. M.Chief Safety Officer: R. S.Chief Engineer: C. S.. Explore Novartis Vaccines's employee directory with LeadIQ.

What industry does Novartis Vaccines belong to?

Minus sign iconPlus sign icon
Novartis Vaccines operates in the Pharmaceutical Manufacturing industry.

What technology does Novartis Vaccines use?

Minus sign iconPlus sign icon
Novartis Vaccines's tech stack includes EnablonSciPyPrometheusSAP BW/4HANANoSQLSeleniumAPSValGenesis iRisk.

What is Novartis Vaccines's email format?

Minus sign iconPlus sign icon
Novartis Vaccines's email format typically follows the pattern of First.Last@novartis.com. Find more Novartis Vaccines email formats with LeadIQ.

How much funding has Novartis Vaccines raised to date?

Minus sign iconPlus sign icon
As of December 2025, Novartis Vaccines has raised $2.4B in funding. The last funding round occurred on Sep 16, 2020 for $2.1B.

Novartis Vaccines

Pharmaceutical ManufacturingMassachusetts, United States5001-10000 Employees

"Caring Begins with Prevention" At Novartis Vaccines and Diagnostics, we believe that caring for patients begins with protecting individuals and societies from infection in the first place. Our innovative vaccines and diagnostics tools are designed to prevent the spread of life-threatening diseases in order to protect vulnerable populations and keep healthy people healthy. Novartis Vaccines and Diagnostics is the world’s fifth-largest vaccines manufacturer and the second-largest supplier of influenza vaccines in the US. In addition, our vaccines portfolio consists of 20 products globally used to prevent the most life-threatening viral and bacterial infections that were once major public health issues. These include meningococcal infections, required immunizations against childhood diseases, and vaccines to protect travelers against diseases endemic to certain regions. Our diagnostics business is dedicated to providing innovative testing solutions to protect the world’s blood supply from transfusion-transmitted diseases. We are the world leader in nucleic acid testing for blood screening.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
5001-10000

Section iconFunding & Financials

  • $2.4B

    Novartis Vaccines has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $100M$250M

    Novartis Vaccines's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $2.4B

    Novartis Vaccines has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $100M$250M

    Novartis Vaccines's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.